Electrocardiographic findings in patients with arrhythmogenic cardiomyopathy and right bundle branch block ventricular tachycardia.

Arrhythmogenic cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy ECG Site of origin Ventricular arrhythmia

Journal

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
ISSN: 1532-2092
Titre abrégé: Europace
Pays: England
ID NLM: 100883649

Informations de publication

Date de publication:
30 03 2023
Historique:
received: 29 08 2022
accepted: 02 12 2022
medline: 3 4 2023
pubmed: 14 1 2023
entrez: 13 1 2023
Statut: ppublish

Résumé

Little is known about patients with right bundle branch block (RBBB)-ventricular tachycardia (VT) and arrhythmogenic cardiomyopathy (ACM). Our aims were: (i) to describe electrocardiogram (ECG) characteristics of sinus rhythm (SR) and VT; (ii) to correlate SR with RBBB-VT ECGs; and (iii) to compare VT ECGs with electro-anatomic mapping (EAM) data. From the European Survey on ACM, 70 patients with spontaneous RBBB-VT were included. Putative left ventricular (LV) sites of origin (SOOs) were estimated with a VT-axis-derived methodology and confirmed by EAM data when available. Overall, 49 (70%) patients met definite Task Force Criteria. Low QRS voltage predominated in lateral leads (n = 37, 55%), but QRS fragmentation was more frequent in inferior leads (n = 15, 23%). T-wave inversion (TWI) was equally frequent in inferior (n = 28, 42%) and lateral (n = 27, 40%) leads. TWI in inferior leads was associated with reduced LV ejection fraction (LVEF; 46 ± 10 vs. 53 ± 8, P = 0.02). Regarding SOOs, the inferior wall harboured 31 (46%) SOOs, followed by the lateral wall (n = 17, 25%), the anterior wall (n = 15, 22%), and the septum (n = 4, 6%). EAM data were available for 16 patients and showed good concordance with the putative SOOs. In all patients with superior-axis RBBB-VT who underwent endo-epicardial VT activation mapping, VT originated from the LV. In patients with ACM and RBBB-VT, RBBB-VTs originated mainly from the inferior and lateral LV walls. SR depolarization and repolarization abnormalities were frequent and associated with underlying variants.

Identifiants

pubmed: 36635857
pii: 6986483
doi: 10.1093/europace/euac267
pmc: PMC10062349
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1025-1034

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology.

Références

Heart Rhythm. 2021 Feb;18(2):163-171
pubmed: 32889109
Int J Cardiol. 2020 Nov 15;319:106-114
pubmed: 32561223
Eur Heart J. 2020 Apr 7;41(14):1414-1429
pubmed: 31637441
Europace. 2016 Dec;18(12):1850-1859
pubmed: 26589624
Circulation. 2020 Jun 9;141(23):1872-1884
pubmed: 32372669
J Am Coll Cardiol. 2018 Aug 14;72(7):784-804
pubmed: 30092956
Eur Heart J. 2010 Apr;31(7):806-14
pubmed: 20172912
J Am Coll Cardiol. 2008 Dec 16;52(25):2175-87
pubmed: 19095136
J Am Heart Assoc. 2018 Nov 20;7(22):e009855
pubmed: 30571483
Heart Rhythm. 2019 Nov;16(11):e373-e407
pubmed: 31676023
Heart Rhythm. 2018 Oct;15(10):1491-1497
pubmed: 29902584
J Am Heart Assoc. 2020 Mar 3;9(5):e014628
pubmed: 32114891
Circ Cardiovasc Genet. 2014 Aug;7(4):455-65
pubmed: 24909667
JACC Clin Electrophysiol. 2017 Jul;3(7):654-665
pubmed: 29759533
Heart Rhythm. 2008 Oct;5(10):1417-21
pubmed: 18783995
Eur Heart J Case Rep. 2020 Jan 25;4(1):1-7
pubmed: 32128479
J Am Coll Cardiol. 2020 Sep 15;76(11):1387-1388
pubmed: 32912451
Circ Arrhythm Electrophysiol. 2020 Dec;13(12):e009005
pubmed: 33197325
Circ Arrhythm Electrophysiol. 2016 Jul;9(7):
pubmed: 27390211
Europace. 2022 Feb 2;24(2):285-295
pubmed: 34491328

Auteurs

Mikael Laredo (M)

Institut de Cardiologie, Groupe Hospitalier Pitié-Salpêtrière, and Sorbonne Université, 47-83 boulevard de l'Hôpital, 75013, Paris, France.

Oholi Tovia-Brodie (O)

Department of Cardiology, Jesselson Integrated Heart Center, Shaare Zedek Medical Center, Jerusalem, Israel.

Anat Milman (A)

Leviev Heart Institute, Sheba Medical Center, Tel-Hashomer and Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Yoav Michowitz (Y)

Department of Cardiology, Jesselson Integrated Heart Center, Shaare Zedek Medical Center, Jerusalem, Israel.

Rob W Roudijk (RW)

Netherlands Heart Institute, Utrecht, The Netherlands.

Giovanni Peretto (G)

IRCCS San Raffaele Scientific Institute, Milan, Italy.

Nicolas Badenco (N)

Institut de Cardiologie, Groupe Hospitalier Pitié-Salpêtrière, and Sorbonne Université, 47-83 boulevard de l'Hôpital, 75013, Paris, France.

Anneline S J M Te Riele (ASJM)

Netherlands Heart Institute, Utrecht, The Netherlands.
Department of Cardiology, University Medical Center, Utrecht, The Netherlands.

Simone Sala (S)

IRCCS San Raffaele Scientific Institute, Milan, Italy.

Guillaume Duthoit (G)

Institut de Cardiologie, Groupe Hospitalier Pitié-Salpêtrière, and Sorbonne Université, 47-83 boulevard de l'Hôpital, 75013, Paris, France.

Elena Arbelo (E)

Arrhythmia Section, Cardiology Department, Hospital Clínic, Universitat de Barcelona, and IDIBAPS, Institut d'Investigació August Pi i Sunyer (IDIBAPS), Barcelona, Spain.

Sandro Ninni (S)

Université de Lille et Institut Cœur-Poumon, CHRU Lille, Lille, France.

Alessio Gasperetti (A)

Department of Cardiology, University Heart Center Zurich, Zurich, Switzerland.

J Peter van Tintelen (JP)

Netherlands Heart Institute, Utrecht, The Netherlands.
Department of Genetics, University Medical Center, Utrecht, The Netherlands.

Gabriele Paglino (G)

IRCCS San Raffaele Scientific Institute, Milan, Italy.

Xavier Waintraub (X)

Institut de Cardiologie, Groupe Hospitalier Pitié-Salpêtrière, and Sorbonne Université, 47-83 boulevard de l'Hôpital, 75013, Paris, France.

Antoine Andorin (A)

Service de Cardiologie, CHU de Nantes, Nantes, France.

Petr Peichl (P)

Department of Cardiology, Institute for Clinical and Experimental Medicine (IKEM), Prague, Czech Republic.

Laurens P Bosman (LP)

Netherlands Heart Institute, Utrecht, The Netherlands.
Department of Cardiology, University Medical Center, Utrecht, The Netherlands.

Leonardo Calo (L)

Division of Cardiology, Policlinico Casilino, Roma, Italy.

Carla Giustetto (C)

Division of Cardiology, University of Torino, Department of Medical Sciences, Città della Salute e della Scienza Hospital, Torino, Italy.

Andrea Radinovic (A)

IRCCS San Raffaele Scientific Institute, Milan, Italy.

Paloma Jorda (P)

Arrhythmia Section, Cardiology Department, Hospital Clínic, Universitat de Barcelona, and IDIBAPS, Institut d'Investigació August Pi i Sunyer (IDIBAPS), Barcelona, Spain.

Ruben Casado-Arroyo (R)

Department of Cardiology, Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium.

Esther Zorio (E)

Cardiology Department at Hospital Universitario y Politecnico La Fe and Research Group on Inherited Heart Diseases, Sudden Death and Mechanisms of Disease (CaFaMuSMe) from the Instituto de Investigación Sanitaria (IIS) La Fe, Valencia, Spain.
Center for Biomedical Network Research on Cardiovascular Diseases (CIBERCV), Madrid, Spain.

Francisco J Bermúdez-Jiménez (FJ)

Cardiology Department, Hospital Universitario Virgen de las Nieves, Granada, Spain.

Elijah R Behr (ER)

Cardiovascular Sciences and Cardiology Clinical Academic Group St. George's University Hospitals NHS Foundation Trust, London, UK.

Stepan Havranek (S)

Second Department of Medicine-Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.

Jacob Tfelt-Hansen (J)

The Department of Cardiology, The Heart Centre, Copenhagen University Hospital, Rigshospitalet, and Section of genetics, Department of Forensic Medicine, Faculty of Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Frederic Sacher (F)

Hôpital Cardiologique du Haut-Lévêque & Université Bordeaux, LIRYC Institute, Bordeaux, France.

Jean-Sylvain Hermida (JS)

Centre Hospitalier Universitaire d'Amiens-Picardie, Amiens, France.

Eyal Nof (E)

Leviev Heart Institute, Sheba Medical Center, Tel-Hashomer and Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Michela Casella (M)

Cardiology and Arrhythmology Clinic, Department of Clinical, Special and Dental Sciences, Marche Polytechnic University, Ancona, Italy.

Josef Kautzner (J)

Department of Cardiology, Institute for Clinical and Experimental Medicine (IKEM), Prague, Czech Republic.

Dominique Lacroix (D)

Université de Lille et Institut Cœur-Poumon, CHRU Lille, Lille, France.

Josep Brugada (J)

Arrhythmia Section, Cardiology Department, Hospital Clínic, Universitat de Barcelona, and IDIBAPS, Institut d'Investigació August Pi i Sunyer (IDIBAPS), Barcelona, Spain.

Firat Duru (F)

Department of Cardiology, University Heart Center Zurich, Zurich, Switzerland.

Paolo Della Bella (PD)

IRCCS San Raffaele Scientific Institute, Milan, Italy.

Estelle Gandjbakhch (E)

Institut de Cardiologie, Groupe Hospitalier Pitié-Salpêtrière, and Sorbonne Université, 47-83 boulevard de l'Hôpital, 75013, Paris, France.

Richard Hauer (R)

Netherlands Heart Institute, Utrecht, The Netherlands.
Department of Cardiology, University Medical Center, Utrecht, The Netherlands.

Bernard Belhassen (B)

Heart Institute, Hadassah University Hospital, Jerusalem and Sackler School of Medicine, Tel-Aviv University, Kyriat Hadassah, PO Box 12000, 91120, Jerusalem, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH